Glaukos (GKOS) Shareholder's Equity Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.18% |
| Dec 31, 2025 | -14.44% |
| Sep 30, 2025 | 15.11% |
| Jun 30, 2025 | 15.03% |
| Mar 31, 2025 | 69.49% |
| Dec 31, 2024 | 66.09% |
| Sep 30, 2024 | 39.96% |
| Jun 30, 2024 | 36.08% |
| Mar 31, 2024 | -11.36% |
| Dec 31, 2023 | -12.88% |
| Sep 30, 2023 | -12.92% |
| Jun 30, 2023 | -13.10% |
| Mar 31, 2023 | -14.90% |
| Dec 31, 2022 | -9.73% |
| Sep 30, 2022 | -8.73% |
| Jun 30, 2022 | -3.74% |
| Mar 31, 2022 | 1.32% |
| Dec 31, 2021 | -12.03% |
| Sep 30, 2021 | -9.15% |
| Jun 30, 2021 | -11.79% |
| Mar 31, 2021 | -8.03% |
| Dec 31, 2020 | -0.86% |
| Sep 30, 2020 | 247.98% |
| Jun 30, 2020 | 252.72% |
| Mar 31, 2020 | 245.73% |
| Dec 31, 2019 | 287.25% |
| Sep 30, 2019 | 16.35% |
| Jun 30, 2019 | 26.44% |
| Mar 31, 2019 | 29.69% |
| Dec 31, 2018 | 25.80% |
| Sep 30, 2018 | 23.70% |
| Jun 30, 2018 | 17.95% |
| Mar 31, 2018 | 16.33% |
| Dec 31, 2017 | 17.85% |
| Sep 30, 2017 | 19.87% |
| Jun 30, 2017 | 19.78% |
| Mar 31, 2017 | 25.39% |
| Dec 31, 2016 | 23.20% |
| Sep 30, 2016 | 16.28% |
| Jun 30, 2016 | 10.92% |
| Dec 31, 2015 | 159.16% |
| Dec 31, 2014 | -7.96% |